Table 1 Per-unit and total costa per medication according to government from August 2015 to June 2016
From: Costs and benefits of bevacizumab vial sharing for the treatment of retinal diseases
| MEDICATION | NUMBER OF APPLICATIONS | COST (in BRL$/USD$) | TOTAL COST (in BRL$/USD$) |
|---|---|---|---|
| Bevacizumab (4 ml) | 192 |
BRL$1291.84 USD$333.42 |
BRL$248,033.28 USD$64,016.84 |
| Ranibizumab | 347 |
BRL$2176.72 USD$561.80 |
BRL$755,321.84 USD$194,946.92 |
| Aflibercept | 11 |
BRL$2972.83 USD$767.28 |
BRL$32,701.13 USD$8440.09 |
| TOTAL | 550 |
BRL$1,036,056.25 USD$267,455.47 |